my guess and "feel" is we are indeed -3 months away from approval. The MHRA went/are going through this application with a fine tooth comb, but they didn't treat it any different than any other biotech that submits a application to them. Its what they do and its essentially their job to find things in the application that need/ warrant explanation, whether its NWBO applying or Biogen. Size of biotech doesn't matter, the MAA process is about scrutizing everything and see if the applying Company can answer the questions to the MHRAs satisfaction. There are no free passes no matter how many times we all have heard, from people on this very board, that approval would be quick and decisive. 500+ days is a long time, but not so considering the gravity DCvax will have in the oncology space. Both George Z and I agreed on this. This guy is very intelligent and has spent time in the scientific realm of biotech with some big players and was a sell side analysis for the big banks. He has seen both sides of the coin...the scientific and financial aspects of this space. One thing is for sure: He didnt strike me as someone who aligns himself with a loser, if you catch my drift.
I wanted to post this because there is so much misinformation going around. The specifics of my convo will remain with me. I suggest to anyone serious investor on this board, to stop listening to the many "talking heads" on this board, both bears and bulls, and get the facts straight from the source. I have read this board for a very long time, and not 1 prediction from anyone has turned out to be true...and trust me there are a lot of "predictions" that have been thrown around here over the years Its all a bunch of BS and truly goes to show how little, as retail investors, we know about the biotech space. Fortunes are lost and made in biotech because of it. Believe nothing what you hear, and everything that you see. The 10k and 8ks tells the tale.
Market Data 
Markets 
